Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: Phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1

التفاصيل البيبلوغرافية
العنوان: Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: Phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1
المؤلفون: Laura Ortega-Moreno, Óscar García-Campos, José Manuel Pardal-Fernández, Alfonso Verdú, Beatriz G. Giráldez, Susana García-Muñozguren, M. Carmen Carrascosa-Romero, José M. Serratosa, Rosa Guerrero-López
المصدر: Neuromuscular Disorders. 25:222-224
بيانات النشر: Elsevier BV, 2015.
سنة النشر: 2015
مصطلحات موضوعية: Pathology, medicine.medical_specialty, Acid Ceramidase, Adolescent, Disease, Progressive myoclonus epilepsy, Muscular Atrophy, Spinal, medicine, Humans, Genetics (clinical), Genetics, Farber disease, business.industry, Homozygote, Muscle weakness, Spinal muscular atrophy, Uniparental Disomy, Myoclonic Epilepsies, Progressive, medicine.disease, Uniparental disomy, Phenotype, Haplotypes, Neurology, Mutation, Pediatrics, Perinatology and Child Health, Mutation (genetic algorithm), ASAH1, Female, Neurology (clinical), medicine.symptom, business, Chromosomes, Human, Pair 8
الوصف: Spinal muscular atrophy and progressive myoclonic epilepsy (SMAPME, OMIM#159950) is a rare autosomal recessive disorder characterized by the combination of progressive myoclonic epilepsy and muscular weakness due to lower motor neuron disease. Mutations in ASAH1, previously associated only to Farber disease, have been recently described in seven patients with SMAPME. A homozygous c.125C>T mutation was initially found in six patients with a clinical homogeneous phenotype. A heterozygous compound mutation found in an additional patient has broadened the clinical and genetic spectrum of clinical SMAPME. We report a new case of a 13-year-old girl with SMAPME with the homozygous ASAH1 c.125C>T mutation, unique in that it is due to paternal uniparental disomy. She experienced muscle weakness from the age of three due to lower motor neuron involvement that lead to severe handicap and onset in late childhood of a progressive myoclonic epilepsy. This clinical picture fully overlaps with that of previously reported patients with this mutation and supports our view that the clinical phenotype associated with the homozygous c.125C>T mutation constitutes a clinically homogenous and recognizable disease.
تدمد: 0960-8966
DOI: 10.1016/j.nmd.2014.11.007
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1024dc1d46c996c18b92e1284b0b442a
https://doi.org/10.1016/j.nmd.2014.11.007
Rights: CLOSED
رقم الانضمام: edsair.doi.dedup.....1024dc1d46c996c18b92e1284b0b442a
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09608966
DOI:10.1016/j.nmd.2014.11.007